Creative Medical Technology Holdings, Inc. (CELZ) stock
CELZNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$0.52−0.01 (-1.51%)
Close on Nov 16, 2026Market cap $3.43MP/E –Yield –
Creative Medical Technology profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Creative Medical Technology's profit margin for the twelve months ending Jun 30, 2026 was -201355.4%. For fiscal 2025 it was -99916.8%, against -49940.7% the year before. The highest annual figure on record is 21892.8% in fiscal 2021.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -99916.8% | −49976.1 |
| FY2024 | Dec 31, 2024 | -49940.7% | +8799.0 |
| FY2023 | Dec 31, 2023 | -58739.7% | −47290.5 |
| FY2022 | Dec 31, 2022 | -11449.3% | −33342.0 |
| FY2021 | Dec 31, 2021 | 21892.8% | +43975.0 |
| FY2020 | Dec 31, 2020 | -22082.2% | −16956.1 |
| FY2019 | Dec 31, 2019 | -5126.1% | +5851.1 |
| FY2018 | Dec 31, 2018 | -10977.2% | +44420.9 |
| FY2017 | Dec 31, 2017 | -55398.1% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q4 FY2025 | Dec 31, 2025 | -62922.5% | −6970.0 |
| Q1 FY2025 | Mar 31, 2025 | -54603.2% | −30370.7 |
| Q4 FY2024 | Dec 31, 2024 | -61802.5% | −28384.8 |
| Q2 FY2024 | Jun 30, 2024 | -19471.6% | −17685.5 |
| Q4 FY2023 | Dec 31, 2023 | -55952.5% | −48253.3 |
| Q3 FY2023 | Sep 30, 2023 | -24232.5% | −18512.6 |
| Q4 FY2022 | Dec 31, 2022 | -33417.7% | −14981.7 |
| Q3 FY2022 | Sep 30, 2022 | -1786.1% | +27265.7 |
| Q1 FY2022 | Mar 31, 2022 | -7699.1% | +212986.6 |
| Q4 FY2021 | Dec 31, 2021 | -5719.9% | −6232.7 |
| Q3 FY2021 | Sep 30, 2021 | -18436.0% | −11831.8 |
| Q2 FY2021 | Jun 30, 2021 | -29051.8% | −37941.3 |
| Q4 FY2020 | Dec 31, 2020 | -220685.7% | −216501.1 |
| Q3 FY2020 | Sep 30, 2020 | 512.8% | +656.0 |
| Q2 FY2020 | Jun 30, 2020 | -6604.2% | −5034.6 |
| Q1 FY2020 | Mar 31, 2020 | 8889.5% | +5531.3 |
| Q3 FY2019 | Sep 30, 2019 | -4184.6% | −1186.4 |
| Q2 FY2019 | Jun 30, 2019 | -143.2% | +133865.2 |
| Q1 FY2019 | Mar 31, 2019 | -1569.6% | +77457.3 |
| Q4 FY2018 | Dec 31, 2018 | 3358.2% | +34133.6 |
| Q3 FY2018 | Sep 30, 2018 | -2998.1% | – |
| Q2 FY2018 | Jun 30, 2018 | -134008.4% | – |
| Q1 FY2018 | Mar 31, 2018 | -79026.9% | – |
| Q4 FY2017 | Dec 31, 2017 | -30775.4% | – |
See a number that looks wrong?